The UK Government has exercised its option to order 40 million doses of Valneva SE’s inactivated, adjuvanted COVID-19 vaccine candidate for supply in 2022.   This brings the total volume of the Valneva vaccine ordered by UK Government to 100 million doses and the UK Government retains options over a further 90 million doses for supply between 2023 and 2025. The total value of the 190 million doses, if all options are exercised, is up to €1.4 billion ($1.7 billion). Valneva has commenced produc...